Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study.
暂无分享,去创建一个
E. Halpern | M. Winniford | L. Wexler | M. Rudnick | S. Goldfarb | P. Ludbrook | M. J. Murphy | J. Hill | M. Cohen | D. VanFossen | M. Murphy | L. Wexler | James A. Hill | D. Vanfossen | Martin B. Cohen | S. Goldfarb | Stanley Goldfarb
[1] R. Katzberg,et al. A comparison of the hemodynamic responses to metrizamide and meglumine/sodium diatrizoate in canine renal angiography. , 1978, Investigative radiology.
[2] J. A. Simpson,et al. RENAL IMPAIRMENT AND ACYCLOVIR , 1981, The Lancet.
[3] J. Cohen,et al. Hospital-acquired renal insufficiency: a prospective study. , 1983, The American journal of medicine.
[4] E. Salomonowitz,et al. Nephrotoxicity of contrast media assessed by occlusion arteriography. , 1984, Radiology.
[5] G. Bakris,et al. A role for calcium in radiocontrast-induced reductions in renal hemodynamics. , 1985, Kidney international.
[6] S. Holtås,et al. Renal Function following Nephroangiography with Metrizamide and Iohexol , 1985, Acta radiologica: diagnosis.
[7] K. Golman,et al. Contrast media-induced nephrotoxicity. Survey and present state. , 1985, Investigative radiology.
[8] L. Fisher,et al. Risks for renal dysfunction with cardiac angiography. , 1986, Annals of internal medicine.
[9] P. Attman,et al. ACUTE RENAL INSUFFICIENCY AFTER ADMINISTRATION OF LOW-OSMOLAR CONTRAST MEDIA , 1986, The Lancet.
[10] B. Strom,et al. Risk factors and outcome of hospital-acquired acute renal failure. Clinical epidemiologic study. , 1987, The American journal of medicine.
[11] Low osmolar contrast agents and nephrotoxicity. , 1987, Annals of internal medicine.
[12] H. Glick,et al. What is the cost of nephrotoxicity associated with aminoglycosides? , 1987, Annals of internal medicine.
[13] Nephrotoxicity of low osmolar radiocontrast agents in patients with chronic renal failure. , 1988, Nephron.
[14] J. Messana,et al. Comparison of the toxicity of the radiocontrast agents, iopamidol and diatrizoate, to rabbit renal proximal tubule cells in vitro. , 1988, The Journal of pharmacology and experimental therapeutics.
[15] L. Hemmingsen,et al. Do contrast media aggravate Fanconi's syndrome in rats? A comparison of diatrizoate, iohexol, and ioxilan. , 1988 .
[16] Urine profiles following intravenous diatrizoate, iohexol, or ioxilan in rats. , 1988 .
[17] A. Jevnikar,et al. Nephrotoxicity of high- and low-osmolality contrast media. , 1988, Nephron.
[18] M. Hlatky,et al. Contrast nephrotoxicity: a randomized controlled trial of a nonionic and an ionic radiographic contrast agent. , 1989, The New England journal of medicine.
[19] R. Nussbaum,et al. Report of the committee on the genetic constitution of the X chromosome. , 1988, Cytogenetics and cell genetics.
[20] D. Feinfeld,et al. Acute renal failure associated with ioxaglate, a low-osmolality radiocontrast agent. , 1989, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[21] A. S. Berns,et al. Nephrotoxicity of contrast media. , 1989, Kidney international.
[22] P. Parfrey,et al. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. , 1989, The New England journal of medicine.
[23] A. Gomes,et al. Acute renal dysfunction in high-risk patients after angiography: comparison of ionic and nonionic contrast media. , 1989, Radiology.
[24] M. Hlatky,et al. Cardiovascular and renal toxicity of a nonionic radiographic contrast agent after cardiac catheterization. A prospective trial. , 1989, Annals of internal medicine.
[25] L. Hillis,et al. Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. , 1989, The American journal of medicine.
[26] P. Parfrey,et al. Contrast Material-Induced Renal Failure in Patients with Diabetes Mellitus, Renal Insufficiency, or Both , 1989 .
[27] Y. Wang,et al. Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography. , 1990, The American journal of medicine.
[28] A. Testa,et al. Randomised prospective study on renal effects of two different contrast media in humans: protective role of a calcium channel blocker. , 1990, Nephron.
[29] R E Vlietstra,et al. A randomized comparison of the nephrotoxicity of iopamidol and diatrizoate in high risk patients undergoing cardiac angiography. , 1991, Journal of the American College of Cardiology.
[30] Nephrotoxicity of contrast media in high-risk patients with renal insufficiency: comparison of low- and high-osmolar contrast agents. , 1991, American journal of nephrology.
[31] J. Lemke,et al. Nephrotoxicity from contrast material in renal insufficiency: ionic versus nonionic agents. , 1991, Radiology.
[32] A. Schoenfeld,et al. Radiocontrast-associated renal dysfunction: a comparison of lower-osmolality and conventional high-osmolality contrast media. , 1991, AJR. American journal of roentgenology.
[33] B. McClennan,et al. Intravascular contrast media. Ionic versus nonionic: current status. , 1991, Radiologic clinics of North America.
[34] O. Blétry,et al. Acute renal failure caused by iopamidol, a nonionic, low-osmolar radiocontrast agent. , 1991, American journal of nephrology.
[35] P. Parfrey,et al. Contrast nephropathy in patients with impaired renal function: high versus low osmolar media. , 1992, Kidney international.
[36] N. Powe,et al. Nephrotoxicity of high-osmolality versus low-osmolality contrast media: randomized clinical trial. , 1992, Radiology.
[37] B. Barrett,et al. Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. , 1993, Radiology.